SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs better-than-expected quarterly results and Googles credit support for financing tied to its Anthropic data-center lease are driving attention. Bulls see the financing and AI infrastructure demand as supportive, while skeptics point to the stocks weak reaction, heavy debt, construction execution risks, and uncertainty around data-center regulation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings sharp selloff follows a Q3 earnings miss and a steep cut to its full-year outlook, with heavy investment in its Predictions business cited as a major drag on expected profitability. Traders are broadly criticizing management, spending and competitive pressures from prediction-market rivals, while some argue the core sportsbook remains healthy and are buying the drop.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year agreement to supply rocket engines, licensed technology, and engineering support for AST SpaceMobiles heavy-lift rocket is drawing attention. Traders largely view the deal as a major commercial validation and potential boost to Fireflys backlog and funding, while some question the execution demands and what the arrangement means for ASTs launch plans.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos rebound is drawing attention after its Q3 business update and a manufacturing agreement reserving capacity for future Aurora reactor components. Bulls see the agreement as progress, while skeptics point to minimal current revenue, long commercialization timelines, and dilution and valuation concerns.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Firefly engine agreement and plan to develop its own heavy-lift rocket have sparked debate over whether greater control of satellite launches can ease a key bottleneck. Traders are split between viewing the move as a long-term strategic step and worrying about its cost, execution risk, and potential dilution.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders await topline survival results from the Phase 3 REGAL trial of its AML drug candidate GPS; the community says the trial reached its 80th event and is in final analysis, with results expected this quarter. Optimism about the readout and separate SLS009 data is running against concern over the sharp share-price decline, with traders debating whether it reflects broad-market pressure or doubts about the company and its prospects.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Concerns that political opposition could slow U.S. data-center construction have fueled selling in AI-related storage and semiconductor stocks, including WDC. Traders debate whether that risk threatens storage demand: bears see a possible buildout slowdown, while bulls point to strong company results and ongoing demand for data storage.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas stronger-than-expected quarterly results and raised revenue outlook, supported by vaccine sales, are driving attention. Traders are split over whether the improved results and pipeline prospects justify the valuation, with skeptics pointing to cash burn and a sharp sell-the-news reversal after the initial rally.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels quarterly results have sparked a sharp selloff, with traders focused on an earnings shortfall and concerns about profitability and legacy-product trends despite VEPPANUs promising early launch. Bulls point to VEPPANUs growth potential and upcoming R289 data, while bears question how quickly the new drug can offset pressure on older products.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is volatile amid a sharp semiconductor selloff and rebound, as traders debate whether election-related calls for tighter data-center rules could slow AI infrastructure spending. Bulls argue demand for its chips remains strong and projects can shift elsewhere, while bears see risks to AI capex and valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are You Looking for a Top Momentum Pick? Why CNO Financial (CNO) is a Great Choice

Does CNO Financial (CNO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why CNO Financial (CNO) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Bear of the Day: Prudential Financial (PRU)

A life insurer's Japan problem just got a longer life of its own. 

AIG Expands Latin American Presence With Everest Insurance Deals

American International expands in Latin America with Everest insurance deals in Colombia and Chile, targeting premium growth in key markets despite integration and profitability risks.

CNO Financial (CNO) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

CNO Financial (CNO) Surpasses Q3 Earnings and Revenue Estimates

CNO (CNO) delivered earnings and revenue surprises of +74.31% and +15.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CNO Financial Group Reports Third Quarter 2026 Results

CNO Financial Group Reports Third Quarter 2026 Results CNO Financial Group Reports Third Quarter 2026 ResultsPR NewswireCARMEL, Ind., Oct. 29, 2026 CARMEL, Ind., Oct. 29, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE: CNO) today reported its third quarter 2026 financial results: Raising 2026...

CNO Financial to Report Q3 Earnings: What Should We Expect?

CNO Financial is set to report third-quarter earnings on Oct. 29, with EPS expected to rise 13.5% despite a projected 16.7% revenue decline. Can insurance growth offset cost pressures?

Are Investors Undervaluing CNO Financial Group (CNO) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Indianapolis Prepares to Celebrate the Sold-Out 19th Annual CNO Financial Indianapolis Monumental Marathon, Half Marathon, & 5K

Indianapolis Prepares to Celebrate the Sold-Out 19th Annual CNO Financial Indianapolis Monumental Marathon, Half Marathon, & 5K Indianapolis Prepares to Celebrate the Sold-Out 19th Annual CNO Financial Indianapolis Monumental Marathon, Half Marathon, & 5KPR NewswireINDIANAPOLIS, Oct. 22, 2026...

• Reported GAAP EPS of $1.90 up 47.29% YoY
• Reported revenue of $1.09B down -8.64% YoY
• CNO raised 2026 operating earnings per share guidance, with the midpoint up 9% from prior guidance; no absolute 2026 operating EPS range was provided in the release.

CNO recorded investment losses, reported holding-company cash and investments of $230.7M versus $351.4M, had a 36.5% debt-to-capital ratio, and cited TechMod expense and favorable actuarial-review impact.

CNO reported a 17th consecutive quarter of new annualized premiums up, consecutive producing-agent-count growth in Consumer and Worksite, 47% quarterly operating EPS growth, and a third Bermuda-affiliate reinsurance transaction.

CNO Financial Group, Inc. is an insurance holding company, which engages in developing, marketing, and administering health insurance, annuity, individual life insurance and other insurance products. It operates through the following segments: Bankers Life, Washington National, and Colonial Penn. The Bankers Life segment markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents and sales managers supported by a network of community-based sales offices. The Washington National segment markets and distributes supplemental health including specified disease, accident and hospital indemnity insurance products and life insurance to middle-income consumers at home and at the worksite. The Colonial Penn segment markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, internet, and telemarketing. The company was founded in 1979 and is headquartered in Carmel, IN.

CNO Financial Group Inc

Neutral Sentiment

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Current Price	$55.69
Prev Close	$56.43
Open	$55.98
Dividend Yield	1.58%
50-Day Moving Average	$54.79
Beta	0.84
Avg. Volume	930,876.67
PE Ratio	12.88

52-Week High	$59.15
52-Week Low	$38.99
Market Capitalization	$5.17B
EPS (Annual)	$2.30
Price to Book	2.23
Revenue Per Employee	$1.36M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CNO Fundamentals